DHL Global Forwarding Life Sciences Conference works with global partners and customers to bring tangible solutions to the problems of managing the health products supply chain. Log-ic is proud to be part of the future of supply chain logistics.
The low proportion of people selected from the general population who were capable of sustaining satisfactory compliance to antihypertension medication may correspond to the maximum effectiveness of medication interventions based on a screening and treatment strategy in the general population. The results stress the need for both high-risk and population approaches to improve hypertension control.
Intelligent Devices Inc., a subsidiary of Information Mediary Corp (IMC), in partnership with Evidencia LLP and Prodecom, announce that the entire line of Log-ic ThermAssureRF devices have received EN12830, IP68, and COFRAC certifications from the French Institute Cemafroid, a United Nations- and World Health Organization (WHO)-authorized testing and certification laboratory.
According to a recent informal poll of Healthcare Packaging (HCP) readers, half the respondents agreed that packaging should enter the stream at the beginning of the clinical trial. An encouraging number, considering the metamorphosis the primary package will likely undergo as the drug formulation continues to change during the course of the trial.
IDTechEx staged its annual conference on Active RFID and Real Time Locating Systems RTLS in Dallas USA 5-6 December. Delegates at over 240 and exhibitors at 20 were again sharply up, reflecting this prosperous and innovative industry. Here we look at aspects relevant to printed electronics. Passive RFID is most amenable to being totally printed because, in most cases, the logic consists of just a memory chip. However, although printing the microprocessors commonly used in active RFID is probably ten years off, the opportunity to print the antennas, sensors, interconnects and batteries is much closer. The primary motivation is to make these devices thinner, flexible and lower in cost.
A new radio frequency identification (RFID) logger combines tracking and tracing with temperature readings, giving processors a way to identify when food safety may have been compromised.
The pharma industry sees great opportunities in using Radio Frequency Identification (RFID) technology during clinical trials, a new survey has revealed.
Winners of the first RFID Excellence in Business Awards, announced today at CMP Technology's RFID World 2007 conference and exhibition, highlight the industry's diversity as well as the business benefits organizations are gaining from this innovative technology. Using RFID, honorees achieved 30 to 50 percent reductions in inventory and labor costs, respectively; 100 percent tag read rates despite temperature and humidity challenges and a 100 times reduction in cost compared with a Global Positioning System (GPS) tracking option.
In October 2006, shipments of Fluvirin influenza vaccine by Novartis arrived at Cardinal Health Care “in either a frozen state and/or below the required storage temperature,” according to a statement on FDA’s Web site. The frozen Fluvirin, which was supplied in 5-ml multidose vials bearing the Chiron Vaccines label, apparently didn’t put patients at any particular risk other than having to be revaccinated. Novartis hasn’t named the cause of the temperature excursion.
Global experts in respiratory disease have called for an immediate increase in efforts to improve the treatment and management of COPD exacerbations. The ‘call' follows heightened political interest in the disease in the UK following recent announcements by the Health Secretary[i] and Chief Medical Officer[ii]. The Exacerbations Taskforce, an international multidisciplinary group of respiratory experts, has published its recommendations in the latest issue of the Primary Care Respiratory Journal[iii].
The market for smart pharma packaging will grow to $1.7bn (€1.3bn) in 2013 from the current $21m, driven by the need for new clinical trial compliance-and brand protection measures, according to a new forecast report.
The Healthcare Compliance Packaging Council (HCPC) is pleased to announce the winner of its annual Compliance Package of the Year competition: Med-ic Digital Package
Information Mediary Corporation has a unique device and software solution to one of the most persistent problems in clinical trials: noncompliance. Its Med-ic ECM (Electronic Compliance Monitor) can be used with any blister package to track medication use without active patient input.
New pharmaceutical packaging for prescription-drug and clinical-trial patients uses electronics to monitor and record drug compliance, which is becoming increasingly critical as the U.S. faces nearly $100 billion in annual healthcare costs related to noncompliance.
Distributing prescription medications in specially designed blister packages rather than in bottles may increase the likelihood that medications will be taken properly, a new study suggests.
Extended-release opiates are state-of-the-art medications for managing moderate to severe chronic pain. They are safe when used as directed, but they do have high potential for abuse and addiction.
New InstaCure formulations allow printing of RFID antennas and complex electronic circuitry, including flexible paper sensors (package security), sensor grids (pharmaceutical packaging monitors), keypads (disposable electronic paper diaries) and backplane components (flexible displays).
The Med-ic eCap uses radio-frequency identification (RFID) technology to track the use of medication without any input from the patient, according to IMC. It consists of an RFID sensor that is embedded in the bottle closure and records when the bottle is opened and closed. The usage data is read using a reader; IMC's CertiScan Software allows the physician, researcher or pharmacist to review the data.
The use of electronic compliance packaging continues to grow, with two recently launched products joining the fray. MeadWestvaco Healthcare Packaging (Mebane, NC) has begun initial testing of Cerepak, an electronic update of its award-winning Dosepak package. Information Mediary Corp. (Ottawa, ON, Canada), meanwhile, is currently testing the Med-ic ECM (electronic compliance monitor) blister package.
Dr. Allan Wilson speaks at the 3rd Annual Forum on Patient Compliance and Persistency, Philadelphia
April 19 2004
Topic: Accelerating Clinical Research through ECM and Digital Packaging: Electronic compliance monitoring (ECM) has evolved over the last decade to where it is now a powerful tool for clinical trials research. Seamlessly integrated into standard medication packaging, ECM offers numerous scenarios for high return on investment (ROI). Professor Wilson will review the evolution of ECM and will present Monte Carlo results showing dramatically the advantages of ECM.
The patient could be reminded by an alarm to take the next dosage. However, with the upwelling of interest in anti-counterfeiting and tamper resistance, the ECM might find its niche as a solution for that problem as well.
FDA News: The new initiative includes creating an internal task force to explore the use of modern technologies and other measures such as stronger enforcement that will make it more difficult for counterfeit drugs to get distributed with - or deliberately substituted for -- safe and effective drugs.
Webdesk: This week's announcement by the FDA regarding the serious and escalating problem of counterfeit pharmaceuticals comes as no surprise to Information Mediary Corporation.
Drug Store News, Chain Pharmacy: The Med-ic Electronic Compliance Monitor could help enhance patient care by automatically tracking the day and time that a patient breaks open a blister foil to take prescribed medication.
Pharmaceutical & Medical Packaging News: Helping improve the accuracy of clinical trial data, blister packaging is fast becoming the package of choice to promote compliance as well as to monitor it.
Smart Labels Analyst IDTechEx Web Journal: A new RFID tag has been developed, claiming to monitor medication usage with any standard blister packaging format.
CPC Healthcare Communications Whitepaper Series: Patient non-compliance is somewhat of a mystery among pharmaceutical manufacturers today, with the majority of them accepting the inevitable fact that a large percentage of their consumers will be non-compliant. These same manufacturers pour millions of dollars into research and development, and into launching a new prescription, but do little to ensure compliance.
Elsevier Patient Education and Counseling:This study examined whether a self-management intervention based on feedback of adherence performance and principles of social cognitive theory improves adherence to antiretroviral dosing schedules. Forty-three individuals with HIV/AIDS who were starting or switching to a new protease inhibitor regimen were randomly assigned to be in a medication self-management program or usual care control group.
Pharmaceutical & Medical Packaging News: As drug manufacturers approach the 21st century, they face a number of challenges. And, surprisingly, packaging can help meet them.
